Genesis HealthCare's roughly $1 billion bankruptcy sale is set to be signed today, with the bankruptcy court asked to confirm the Chapter 11 exit on Tuesday. Rehinged's data lists 191 scored facilities under the Genesis name, and more than half of them are rated two stars or below. Separately, a Maryland home owned by Genesis has asked the U.S. Supreme Court to decide whether CMS can levy a $1.5 million infection control penalty without a jury trial.
Why it matters for vendors: The 191 Genesis facilities average 2.36 stars against 2.98 nationally, and 111 of them sit at two stars or below, so the incoming owner inherits a turnaround book that will re-paper vendor contracts. The Supreme Court petition is a long shot with no timetable, but 337 facilities already carry high penalty risk and $88.6 million in cumulative fines, and that demand does not wait for the Court. Turnaround and survey-readiness vendors should work Pennsylvania, West Virginia and New Mexico now; penalty-avoidance vendors should start in Illinois.
M&A / OwnershipRegulatory
Genesis Closes In on a Roughly $1 Billion Sale, With Court Confirmation Set for Tuesday
What happened
Attorneys for Genesis HealthCare spent more than 40 hours this week reworking the purchase agreement for a nearly $1 billion sale to 101 W. State Street, which won the second auction with a $996 million bid. The sale is expected to be executed today, and the bankruptcy court has been asked to confirm the Chapter 11 exit on Tuesday. The revised deal gives the buyer more favorable lease terms on some properties and sends about $15 million more to creditors, and Health Care Services Group, Genesis's largest creditor, signaled its approval at Thursday's hearing.
Why it matters
Once the sale closes, the buyer can sell or reorganize assets immediately. Any facility that changes hands, changes lessor or changes management will reopen its vendor decisions, from pharmacy and therapy to staffing agencies and software. The window for vendors is the first stretch after closing, before a new owner standardizes its purchasing.
Rehinged Intelligence analysis of 14,690 scored facilities finds 191 facilities operating under the Genesis name, about 22,400 beds across 19 states. They average 2.36 stars against 2.98 for the national field, and 111 of them, or 58%, are rated two stars or below, compared with 41% of all scored facilities. Cumulative federal fines at the 191 total $8.8 million. This is the operator list in our data as of the August 2026 scoring cycle; individual facilities may already have changed hands.
191
Genesis-operated facilities
111
rated two stars or below
27
with high infection prevention need
Average overall rating
Genesis facilities
2.36 stars
All scored facilities
2.98 stars
Genesis-operated facilities by state
The compound picture is a portfolio that is weak on quality and uneven on infection control. The 27 Genesis facilities with a high infection prevention score average just 1.48 stars and carry $1.4 million in cumulative fines, and seven of them are in New Mexico, six in West Virginia, and five each in Maine and Pennsylvania. Genesis's nursing turnover averages 46.0%, essentially the national rate of 45.9%, so staffing is not the outlier here; quality and survey performance are. Vendors selling survey-readiness, infection control and clinical quality programs should lead with Pennsylvania, West Virginia and New Mexico, which together hold 89 of the 191 facilities, and should ask for the new owner's procurement contacts this month rather than waiting for the first consolidation announcement.
Watch for: Tuesday's confirmation hearing, and the first announcements of asset sales, lease changes or management transitions at individual Genesis facilities.
RegulatoryInfection Prevention
A Genesis-Owned Maryland Home Asks the Supreme Court to Rule That CMS Cannot Fine Without a Jury Trial
What happened
Sligo Creek Center, a Maryland nursing home owned by Genesis, filed a petition Monday asking the U.S. Supreme Court to hold that CMS cannot impose a $1.5 million infection control penalty without offering a jury trial. The fine stems from a 2016 tuberculosis outbreak. The facility argues that the Court's 2024 Jarkesy decision, which barred the Securities and Exchange Commission from assigning civil penalties without a right to trial, should reach HHS. The Fourth Circuit ruled against the facility in June. The facility is now represented by Pacific Legal Foundation, and the fine remains in escrow until the Court acts.
Why it matters
The Court takes fewer than 150 of the more than 7,000 petitions it receives each year, and the case offers a circuit split and a chance to clarify Jarkesy, so it is a contender but still a long shot. If the justices took it up and extended Jarkesy, the leverage behind CMS civil money penalties would be in question. Any ruling is many months away, and the enforcement system that drives compliance spending today is unchanged.
Rehinged Intelligence analysis of 14,690 scored facilities finds 337 facilities with a high penalty risk score, just 2.3% of the field. They average only 1.28 stars, have 55.6% nursing turnover against 45.9% nationally, and carry $88.6 million in cumulative fines, which is 19% of the $457 million levied across all scored facilities. The exposure is concentrated: 132 of the 337, or 39%, are in Illinois.
337
facilities with high penalty risk
56
also with high infection prevention need
High-penalty-risk facilities by state
The Sligo Creek profile, a penalty built on an infection control failure, is the overlap that matters most commercially. 56 facilities score high on both penalty risk and infection prevention need, averaging 1.25 stars and $14.1 million in cumulative fines, with 15 in Illinois and 10 in California. A narrower group of 33 facilities already has an infection control citation and fines on the books alongside a high infection prevention score, with $4.5 million in fines among them. Vendors selling infection control programs, environmental services, surveillance and survey-readiness consulting should start in Illinois and California and sell on today's enforcement, not on the outcome of a petition the Court may never grant.
Watch for: Whether the Court calls for a response or grants review, and the parallel Rosewood Rehabilitation case that Pacific Legal is pursuing in the Second Circuit over NLRB penalties.